PMV Pharmaceuticals (PMVP)

• Market cap: $95.8M
• 1 day: 5.88%
• 5 days: 73.08%
• 1 month: 69.81%
• 3 months: 46.34%
• 6 months: 20.81%
• Year to date: 46.34%
• 1 year: 36.36%
• 5 years: -94.86%
• 10 years: -95.2%
• Sector: Healthcare
• Industry: Biotechnology

About: PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. Its pipeline rezatapopt PYNNACLE, rezatapopt and azacitidine, rezatapopt (PC14586), and PMV-586-101.

Employees: 47